218 related items for PubMed ID: 3216557
21. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.
Zimmerman SW.
Clin Nephrol; 1984 Jul; 22(1):32-8. PubMed ID: 6383672
[Abstract] [Full Text] [Related]
22. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
Masutani K, Katafuchi R, Ikeda H, Yamamoto H, Motoyama K, Sugitani A, Kanai H, Kumagai H, Hirakata H, Tanaka M, Iida M.
Clin Transplant; 2005 Jul; 19 Suppl 14():59-64. PubMed ID: 15955171
[Abstract] [Full Text] [Related]
23. Nephrotic syndrome due to preeclampsia. Incidence of focal and segmental glomerular sclerosis.
Nadal MA, Monserrat AJ, Iotti RM, Delfino CJ, Gotlieb D.
Medicina (B Aires); 1986 Jul; 46(2):157-62. PubMed ID: 3574066
[No Abstract] [Full Text] [Related]
24. Impact of low-density lipoprotein apheresis for nephrotic syndrome in a patient with immunoglobulin M nephropathy.
Tanaka A, Nakamura T, Sato E, Node K.
Nephrology (Carlton); 2016 Dec; 21(12):1073-1074. PubMed ID: 27870230
[No Abstract] [Full Text] [Related]
25. [LDL-apheresis for refractory nephrotic syndrome].
Muso E.
Nihon Jinzo Gakkai Shi; 2010 Dec; 52(7):928-33. PubMed ID: 21077343
[No Abstract] [Full Text] [Related]
26. Apheresis for Kidney Disease.
Furuichi K, Wada T.
Contrib Nephrol; 2018 Dec; 196():188-193. PubMed ID: 30041226
[Abstract] [Full Text] [Related]
27. Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report.
Ideura T, Hora K, Kaneko Y, Yamazaki T, Tokunaga S, Shigematsu H, Kiyosawa K.
Transplant Proc; 2000 Feb; 32(1):223-6. PubMed ID: 10701029
[No Abstract] [Full Text] [Related]
28. Umbilical Cord Blood Transplantation-associated Nephrotic Syndrome Successfully Treated by Low-density Lipoprotein Apheresis.
Sugawara Y, Honda K, Katagiri D, Nakamura M, Kawakami T, Nasu R, Hayashi A, Shintani Y, Tojo A, Noiri E, Kurokawa M, Fukayama M, Nangaku M.
Intern Med; 2016 Feb; 55(19):2831-2836. PubMed ID: 27725544
[Abstract] [Full Text] [Related]
29. Low density lipoprotein apheresis ameliorates interferon-γ production in patients with nephrotic syndrome.
Miyata H, Uno K, Ono T, Yashiro M, Fukatsu A, Kita T, Kimura T, Muso E.
Ther Apher Dial; 2012 Apr; 16(2):189-94. PubMed ID: 22458400
[Abstract] [Full Text] [Related]
30. Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
Bramlage CP, Armstrong VW, Zapf A, Bramlage P, Mueller GA, Koziolek MJ.
Ther Apher Dial; 2010 Apr; 14(2):136-42. PubMed ID: 20438534
[Abstract] [Full Text] [Related]
31. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
Muso E.
Clin Exp Nephrol; 2014 Apr; 18(2):286-90. PubMed ID: 24535024
[Abstract] [Full Text] [Related]
32. Recurrence of nephrotic syndrome in focal segmental glomerulosclerosis after transplantation.
Itami N, Akutus Y, Hattori M, Itoh K.
Pediatr Nephrol; 1990 May; 4(3):298-9. PubMed ID: 2400660
[No Abstract] [Full Text] [Related]
33. Focal segmental glomerulosclerosis, crescent, and rapidly progressive renal failure.
Ramirez F, Travis LB, Cunningham RJ, Cavallo T, Rajarman S, Brouhard BH, Ellis EN.
Int J Pediatr Nephrol; 1982 Sep; 3(3):175-8. PubMed ID: 7141789
[Abstract] [Full Text] [Related]
34. Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients.
Al-Mousily M, Nicoara O, Selewski DT, Twombley K.
Pediatr Nephrol; 2022 Mar; 37(3):585-592. PubMed ID: 34453196
[Abstract] [Full Text] [Related]
35. [Therapeutic apheresis in the treatment of drug-resistant primary glomerulonephritis].
Sakai S, Sakai O.
Nihon Rinsho; 1992 Jan; 50 Suppl():139-47. PubMed ID: 1578669
[No Abstract] [Full Text] [Related]
36. Rituximab-Resistant Nephrotic Syndrome With Successful Induction of Remission by Low-Density Lipoprotein Apheresis.
Suzuki H, Tsukamoto T, Muso E.
Ther Apher Dial; 2017 Jun; 21(3):295-296. PubMed ID: 28661090
[No Abstract] [Full Text] [Related]
37. Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients.
Al-Mousily MF, Nicoara O, Selewski DT, Nadig S, Twombley K.
J Clin Apher; 2022 Aug; 37(4):411-414. PubMed ID: 35238425
[Abstract] [Full Text] [Related]
38. Relapse of nephrotic syndrome following remission for 20 years.
Cuoghi D, Vangelista A, Baraldi A, Cheli E.
Int J Pediatr Nephrol; 1983 Sep; 4(3):211-4. PubMed ID: 6315615
[Abstract] [Full Text] [Related]
39. Focal and segmental glomerulosclerosis causing nephrotic syndrome in adults.
Chaubey BS, Dallal PR, Grover S.
J Assoc Physicians India; 1976 May; 24(5):277-82. PubMed ID: 1022759
[No Abstract] [Full Text] [Related]
40. Collapsing focal segmental glomerulosclerosis successfully treated with combination of steroid pulse and low-density lipoprotein apheresis: lessons for the clinical nephrologist.
Furuto Y, Hashimoto H, Kawamura M, Horiuchi H, Shibuya Y.
J Nephrol; 2022 May; 35(4):1279-1282. PubMed ID: 34846714
[No Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
